dipyridamole has been researched along with Cardiomegaly in 30 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a population of patients with chronic renal failure (CRF) and a high prevalence of left ventricular hypertrophy (LVH) undergoing chronic hemodialysis, we investigated the association between the results of dipyridamole-thallium tests (DTTs) and the occurrence of ventricular arrhythmias." | 7.68 | Dipyridamole-thallium tests are predictive of severe cardiac arrhythmias in patients with left ventricular hypertrophy. ( Barbieri, A; Canziani, ME; Cassiolato, JL; Castiglioni, ML; Draibe, SA; Gil, MA; Lima, VC; Martinez, EE; Saragoça, MA, 1991) |
| "Furthermore." | 5.30 | Valsartan and coronary haemodynamics in early post-myocardial infarction in rats. ( De Gasparo, M; Fornes, P; Gervais, M; Giudicelli, JF; Richer, C, 1999) |
| "In a population of patients with chronic renal failure (CRF) and a high prevalence of left ventricular hypertrophy (LVH) undergoing chronic hemodialysis, we investigated the association between the results of dipyridamole-thallium tests (DTTs) and the occurrence of ventricular arrhythmias." | 3.68 | Dipyridamole-thallium tests are predictive of severe cardiac arrhythmias in patients with left ventricular hypertrophy. ( Barbieri, A; Canziani, ME; Cassiolato, JL; Castiglioni, ML; Draibe, SA; Gil, MA; Lima, VC; Martinez, EE; Saragoça, MA, 1991) |
| " The transient dyssynergy detected by two-dimensional echocardiography and evoked during dipyridamole infusion is a marker of coronary disease that is equally reliable in normotensive and hypertensive individuals." | 3.68 | Dipyridamole echocardiography stress testing in hypertensive patients. Targets and tools. ( Camici, P; L'Abbate, A; Lattanzi, F; Lucarini, AR; Marini, C; Picano, E; Salvetti, A, 1991) |
| "Furthermore." | 1.30 | Valsartan and coronary haemodynamics in early post-myocardial infarction in rats. ( De Gasparo, M; Fornes, P; Gervais, M; Giudicelli, JF; Richer, C, 1999) |
| "Cardiac hypertrophy is associated with a decrease in coronary reserve." | 1.26 | Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve. ( Marcus, ML; Peters, KG; Tomanek, RJ; Wangler, RD, 1982) |
| "In dogs with experimental cardiac hypertrophy in resting conditions, coronary blood flow and myocardial O2 consumption increased proportionately to the cardiac mass; coronary flow and O2 consumption per gram of myocardium, therefore, ranged within normal values." | 1.26 | Coronary blood flow and myocardial O2 consumption in hypertrophied cardiac muscle in dogs. ( Marchetti, GV; Merlo, L; Visioli, O, 1976) |
| "The dipyridamole treatment had no effect on the increase in systolic pressure, the contractility index of the aorta-stenosed animals and heart rate." | 1.25 | [Variation of mechanical and biochemical parameters of pressure-loaded rabbit hearts following chronic administration of dipyridamole]. ( Förster, W; Ritter, C; Weiss, M, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (63.33) | 18.7374 |
| 1990's | 11 (36.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ESPLUGUES, J | 1 |
| BRUGGER, A | 1 |
| HUESO, E | 1 |
| SOTO, L | 1 |
| Wangler, RD | 2 |
| Peters, KG | 2 |
| Marcus, ML | 2 |
| Tomanek, RJ | 3 |
| Thormann, J | 1 |
| Marchant, E | 1 |
| Pichard, A | 1 |
| Casanegra, P | 1 |
| Rodríguez, JA | 1 |
| Chamorro, G | 1 |
| Corbalán, R | 1 |
| DePace, NL | 1 |
| Burke, W | 1 |
| Kotler, MN | 1 |
| Glazier, EE | 1 |
| Takata, J | 1 |
| Counihan, PJ | 1 |
| Gane, JN | 1 |
| Doi, Y | 1 |
| Chikamori, T | 1 |
| Ozawa, T | 1 |
| McKenna, WJ | 1 |
| Kozàkovà, M | 1 |
| Palombo, C | 1 |
| Pratali, L | 1 |
| Pittella, G | 1 |
| Galetta, F | 1 |
| L'Abbate, A | 2 |
| Gervais, M | 1 |
| Richer, C | 1 |
| Fornes, P | 1 |
| De Gasparo, M | 1 |
| Giudicelli, JF | 1 |
| Strauer, BE | 1 |
| Ritter, C | 2 |
| Förster, W | 4 |
| Blass, KE | 2 |
| Triebe, G | 2 |
| Traub, F | 1 |
| Weiss, M | 1 |
| Marchetti, GV | 1 |
| Merlo, L | 1 |
| Visioli, O | 1 |
| Degenring, FH | 1 |
| Curnish, RR | 1 |
| Rubio, R | 1 |
| Berne, RM | 1 |
| Kupper, W | 1 |
| Bleifeld, W | 1 |
| Hanrath, P | 1 |
| Hamm, C | 1 |
| Mathey, D | 1 |
| Waag, KL | 1 |
| Mittmann, U | 1 |
| Keller, HE | 1 |
| Schäfer, H | 1 |
| Schwierczenski, A | 1 |
| Torry, RJ | 1 |
| O'Brien, DM | 1 |
| Connell, PM | 1 |
| Prisant, LM | 2 |
| von Dohlen, TW | 2 |
| Houghton, JL | 2 |
| Carr, AA | 2 |
| Frank, MJ | 2 |
| Saragoça, MA | 1 |
| Canziani, ME | 1 |
| Gil, MA | 1 |
| Castiglioni, ML | 1 |
| Cassiolato, JL | 1 |
| Barbieri, A | 1 |
| Lima, VC | 1 |
| Draibe, SA | 1 |
| Martinez, EE | 1 |
| Lucarini, AR | 1 |
| Picano, E | 1 |
| Lattanzi, F | 1 |
| Camici, P | 1 |
| Marini, C | 1 |
| Salvetti, A | 1 |
| Marwick, TH | 1 |
| Cook, SA | 1 |
| Lafont, A | 1 |
| Underwood, DA | 1 |
| Salcedo, EE | 1 |
| Goldstein, RA | 1 |
| Haynie, M | 1 |
| Schelbert, HR | 1 |
| Czernin, J | 1 |
| Chilian, WM | 1 |
| Clozel, JP | 1 |
| Hefti, F | 1 |
| DePuey, EG | 1 |
| Guertler-Krawczynska, E | 1 |
| Perkins, JV | 1 |
| Robbins, WL | 1 |
| Whelchel, JD | 1 |
| Clements, SD | 1 |
| Swan, H | 1 |
| Meagher, DM | 1 |
| Wussling, M | 1 |
| Szymanski, G | 1 |
| Schrör, K | 1 |
1 review available for dipyridamole and Cardiomegaly
| Article | Year |
|---|---|
[Quantitative determination of coronary reserve in diagnosis of coronary circulatory disorders].
Topics: Adrenergic beta-Antagonists; Cardiomegaly; Cardiomyopathies; Collagen Diseases; Coronary Circulation | 1977 |
29 other studies available for dipyridamole and Cardiomegaly
| Article | Year |
|---|---|
[INVERSION OF THE CORONARY DILATOR EFFECT OF SOME DRUGS BY ERGOTAMINE TARTRATE].
Topics: Animals; Blood Circulation; Cardiomegaly; Coronary Vessels; Dipyridamole; Dogs; Ergotamine; Papaveri | 1963 |
Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve.
Topics: Animals; Cardiomegaly; Coronary Circulation; Dipyridamole; Disease Models, Animal; Hypertension; Mal | 1982 |
[Effect of tachycardia on hemodynamics and coronary circulation. Different relevance of ventricular tachycardias for healthy persons, coronary patients and patients with left heart hypertrophy].
Topics: Aortic Valve; Aortic Valve Stenosis; Cardiac Pacing, Artificial; Cardiomegaly; Coronary Circulation; | 1984 |
[Coronary circulation in patients with left ventricular hypertrophy].
Topics: Blood Pressure; Cardiac Catheterization; Cardiomegaly; Coronary Circulation; Dipyridamole; Echocardi | 1984 |
An unusual case of Bjork-Shiley mitral valve dysfunction corrected nonsurgically.
Topics: Aspirin; Cardiomegaly; Dipyridamole; Echocardiography; Female; Furosemide; Heart Murmurs; Heart Valv | 1981 |
Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain.
Topics: Adolescent; Adult; Aged; Cardiomegaly; Cardiomyopathy, Hypertrophic; Chest Pain; Chi-Square Distribu | 1993 |
Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography.
Topics: Adult; Aged; Angina Pectoris; Blood Flow Velocity; Blood Pressure; Cardiomegaly; Coronary Vessels; D | 1997 |
Valsartan and coronary haemodynamics in early post-myocardial infarction in rats.
Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Body Weigh | 1999 |
[The effect of oxyfedrine, prenylamine and dipyridamole on heart hypertrophy and collagen concentration of pressure loaded rat hearts].
Topics: Animals; Blood Pressure; Cardiomegaly; Collagen; Dipyridamole; Heart; Heart Rate; Myocardium; Oxyfed | 1976 |
Influence of long-term treatment with dipyridamole on the aorta-stenosed rabbit heart: morphometric and functional investigations.
Topics: Animals; Aortic Valve Stenosis; Blood Pressure; Cardiomegaly; Dipyridamole; Disease Models, Animal; | 1976 |
[Variation of mechanical and biochemical parameters of pressure-loaded rabbit hearts following chronic administration of dipyridamole].
Topics: Animals; Cardiomegaly; Dipyridamole; Heart; Hemodynamics; Hydroxyproline; Myocardium; Rabbits | 1975 |
Coronary blood flow and myocardial O2 consumption in hypertrophied cardiac muscle in dogs.
Topics: Animals; Cardiac Output; Cardiomegaly; Coronary Circulation; Dipyridamole; Dogs; Myocardium; Nitrogl | 1976 |
Effect of dipyridamole on myocardial adenosine metabolism and coronary flow in hypoxia and reactive hyperemia in the isolated perfused guinea pig heart.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cardiome | 1976 |
[Circulatory and metabolic action of pressure-induced cardiac hypertrophy in rest, during exercise and following medicinal dilatation of the coronary vessels].
Topics: Aortic Valve Stenosis; Cardiomegaly; Coronary Circulation; Dipyridamole; Humans; Lactates; Oxygen; P | 1977 |
[Subendocardial jeopardy of the hypertrophied myocardium].
Topics: Animals; Cardiomegaly; Coronary Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; Dogs; | 1979 |
Dipyridamole-induced capillary growth in normal and hypertrophic hearts.
Topics: Animals; Capillaries; Cardiomegaly; Coronary Circulation; Dipyridamole; Hypertension, Renal; Male; N | 1992 |
A negative thallium (+/- dipyridamole) stress test excludes significant obstructive epicardial coronary artery disease in hypertensive patients.
Topics: Adult; Cardiomegaly; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography; Exercis | 1992 |
Dipyridamole-thallium tests are predictive of severe cardiac arrhythmias in patients with left ventricular hypertrophy.
Topics: Adolescent; Aged; Arrhythmias, Cardiac; Cardiomegaly; Dipyridamole; Female; Humans; Middle Aged; Pre | 1991 |
Dipyridamole echocardiography stress testing in hypertensive patients. Targets and tools.
Topics: Cardiomegaly; Coronary Disease; Dipyridamole; Echocardiography; Exercise; Humans; Hypertension; Micr | 1991 |
Influence of left ventricular mass on the diagnostic accuracy of myocardial perfusion imaging using positron emission tomography with dipyridamole stress.
Topics: Adult; Aged; Cardiomegaly; Coronary Disease; Dipyridamole; Echocardiography; Female; Humans; Male; M | 1991 |
Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease.
Topics: Cardiac Catheterization; Cardiomegaly; Coronary Circulation; Coronary Disease; Dipyridamole; Echocar | 1990 |
Limited myocardial perfusion reserve in patients with left ventricular hypertrophy.
Topics: Cardiomegaly; Coronary Circulation; Dipyridamole; Exercise; Female; Heart; Humans; Male; Nitrogen Ra | 1990 |
Noninvasive quantification of regional myocardial blood flow: assessment of myocardial perfusion reserve and collateral circulation.
Topics: Cardiomegaly; Collateral Circulation; Coronary Circulation; Coronary Disease; Dipyridamole; Exercise | 1990 |
Thyroxine-induced left ventricular hypertrophy in the rat. Anatomical and physiological evidence for angiogenesis.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Body Weight; Capillaries; Cardiomegaly; Coronary Circu | 1985 |
Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Cilazapril; Coronary C | 1988 |
Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography.
Topics: Cardiomegaly; Diagnosis, Differential; Dipyridamole; Echocardiography; Female; Heart; Humans; Hypert | 1988 |
Total body bypass in miniature pigs. Postperfusion pulmonary hypertension.
Topics: Acidosis; Anesthesia, Inhalation; Animals; Blood Group Incompatibility; Blood Pressure; Capillary Pe | 1971 |
[Influence of long-term treatment with dipyridamole on the contractility and development of hypertrophy in rabbit heart with aortic stenois].
Topics: Animals; Aortic Valve Stenosis; Blood Pressure; Body Weight; Cardiomegaly; Dipyridamole; Female; Hea | 1972 |
The influence of hypertrophy and hypoxia on potentiation phenomena of the rabbit papillary muscle tested by a double rest programme.
Topics: Animals; Aortic Valve Stenosis; Calcium; Cardiomegaly; Dipyridamole; Electric Stimulation; Heart Ven | 1974 |